Cardiogenic Shock Registry Mannheim — CARESMA  

Cardiogenic Shock Clinical Trial

Official title: Cardiogenic Shock Registry Mannheim - CARESMA

Status Recruiting

Clinical Trial Summary

The study aims to investigate clinically and prognostically relevant parameters in patients with cardiogenic shock within a monocentric observational clinical register.

Clinical Trial Description

All consecutive patients with a confirmed cardiogenic shock presenting at the internal intensive care Unit (ICU) at the University of Mannheim are included in the register and followed up during ICU stay and after that. Data of patients' admission status, cause of cardiogenic shock, baseline parameters and comorbidities are collected. Extensive information about echocardiography, electrocardiography and imaging procedures are included in the register. Laboratory values, microbiological investigations, organ dysfunction and organ replacement therapies, medication, adverse events, and complications were recorded for several days during the ICU stay (days 1, 2, 3, 5, 7, and 8). Standard scores for critically ill patients were calculated for the day of admission at the ICU if available, and several time points during the ICU stay. The register includes information about the mortality during ICU stay, 30-day mortality, 6-month mortality and 1-year mortality. ;

Related Conditions & MeSH terms

• Cardiogenic Shock
• Shock
• Shock, Cardiogenic

• NCT number: NCT05575856
• Study type: Observational [Patient Registry]
• Source: Universitätsmedizin Mannheim
• Contact: Michael Behnes, PhD
• Phone: 0049621-3836239
• Email: michael.behnes@umm.de
• Status: Recruiting
• Start date: June 1, 2019
• Completion date: December 1, 2023